Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Technology

[Exclusive] Jeon Seong-woo, CEO of Finemedix Co., Ltd.: "Partnership Agreement with a Top 10 Global Healthcare Company Imminent... Revenue Expected to Exceed 15 Billion Won"

"We are preparing to sign a contract with a global company. We are now focusing more on how to sell our products rather than how to make good ones."Jeon Seong-woo, CEO of #Finemedix Co., Ltd., made th…
  • 2026-10-06 11:02:02
  • Kim Seung-kwon
Lifestyle

[Exclusive] BrainOn’s ‘Seracue’ Notified of Suspension of Transactions by Major Clients… ‘On Track to Be Ousted from the Industry’

“Cera-Q,” a product by BrainOn Co., Ltd., which was distributed under false pretenses—passing off ingredients not recognized as having functional benefits by the Ministry of Food and Drug Safety (MFDS…
  • 2026-10-05 08:01:04
  • YU JIN-HEE
Technology

Roche's Choice: HanmiPharm's New Obesity Drug; Vice President Choi In-young Says, "We Wanted to Lose Fat and Gain Muscle"

Lose fat while preserving muscle. As Roche has discontinued emugrovat—a candidate it was developing to counteract muscle loss during obesity treatment—the role of “HM17321,” a technology licensed by H…
  • 2026-10-05 07:16:02
  • NA EUN-KYUNG
Technology

Kwak Young-shin, Director of the OSCOTEC Inc. Research Institute: “OCT-648, Targeting Technology Transfer Next Year… Currently in Discussions with Big Pharma”

OSCOTEC Inc.(039200)OSCOTEC Inc. is aiming for a technology export deal led by “OCT-648,” a candidate drug for the treatment of fibrosis in chronic kidney disease. Having already successfully commerci…
  • 2026-10-05 07:01:03
  • KIM SUNG-JIN
Technology

Jeong Sang-won, CEO of Embricks: “Realizing In-Body CAR-T”… The Secret to Weathering the Investment Slump

(Graphic: ChatGPT) “While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…
  • 2026-10-04 07:32:02
  • Minji Son
Technology

A-Sleep Partners with Hyundai Engineering & Construction and Samsung Electronics on 'Sleep Orchestra'… "We Will Create a Wall Pad for the Bedroom"

A-Sleep is partnering with Hyundai Engineering & Construction, Samsung Electronics, and others to fully launch its “Sleep Orchestra” business, which automatically controls the bedroom environment. The…
  • 2026-10-04 07:02:03
  • Kim Seung-kwon
Lifestyle

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
  • 2026-10-03 07:22:03
  • Kim Jinsoo
Lifestyle

G.I. Innovation and G2G Rise 20% on Expectations of Technology Exports [Bio Spotlight]

On the 1st, the KRX Healthcare Index rose 4.53% compared to the previous trading day, bringing a rare breath of fresh air to the pharmaceutical and biotech industry. Amid this, GI Innovation Inc.(3585…
  • 2026-10-03 07:22:02
  • Kim Jinsoo
Technology

[Caregen Co.,LTD. Deep Dive ①] The Truth Behind Caregen Co.,LTD.’s “Hundreds of Billions of Won Contract”… A 240 Billion Won Contract with a 9-Year Fulfillment Rate of 1.2%

Caregen Co.,LTD.(214370)has recently announced a series of overseas supply contracts worth hundreds of billions of won. However, given that many of its past major supply contracts ended with low fulfi…
  • 2026-10-02 10:02:01
  • KIM SAE-MI
Lifestyle

"Typhoid: 20 billion... Meningococcal: 100 billion"... EuBiologics Co., Ltd. Kicks Off Its "Post-Cholera Cash Cow" Initiative

EuBiologics Co., Ltd.(206650)is accelerating efforts to secure new revenue streams, led by its typhoid and meningococcal vaccines. EuBiologics Co., Ltd.’s strategy to expand its vaccine portfolio. …
  • 2026-10-02 08:41:02
  • KIM JI-WAN
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English